The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikolic, B.
Right arrow Articles by Sykes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolic, B.
Right arrow Articles by Sykes, M.
The Journal of Immunology, 2001, 166: 1398-1404.
Copyright © 2001 by The American Association of Immunologists

Both {gamma}{delta} T Cells and NK Cells Inhibit the Engraftment of Xenogeneic Rat Bone Marrow Cells and the Induction of Xenograft Tolerance in Mice1

Boris Nikolic2, David T. Cooke2, Guiling Zhao and Megan Sykes3

Bone Marrow Transplantation Section, Transplantation Biology Research Center, Surgical Service, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129

In murine allogeneic bone marrow transplantation recipients, treatment of the hosts with a nonmyeloablative regimen, including depleting anti-CD4 and anti-CD8 mAbs, allows establishment of long-term mixed chimerism and donor-specific tolerance. However, in the xenogeneic rat-to-mouse combination, additional anti-Thy1.2 and anti-NK1.1 mAbs are required. We have now attempted to identify the xenoresistant mouse cell populations that are targeted by anti-NK1.1 and anti-Thy1.2 mAbs. C57BL/6 (B6) wild-type, B6 TCR{beta}-/-, and B6 TCR{delta}-/- mice received anti-CD4 and anti-CD8 mAbs, followed by 3 Gy of whole body irradiation, 7 Gy of thymic irradiation, and transplantation of T cell-depleted rat bone marrow cells. Anti-NK1.1 and anti-Thy1.2 mAbs were additionally administered to some groups. Increased rat chimerism was observed in TCR{delta}-/- mice treated with anti-CD4, anti-CD8, and anti-NK1.1 mAbs compared with similarly treated TCR{beta}-/- mice. In TCR{beta}-/- mice, but not in TCR {delta}-/- mice, donor chimerism was increased by treatment with anti-Thy1.2 mAb, indicating that CD4-CD8-TCR{gamma}{delta}+Thy1.2+NK1.1- cells ({gamma}{delta} T cells) are involved in the rejection of rat marrow. In addition, chimerism was enhanced in both TCR{beta}-/- and TCR{delta}-/- mice treated with anti-CD4, anti-CD8, and anti-Thy1.2 mAbs by the addition of anti-NK1.1 mAb to the conditioning regimen. Donor-specific skin graft prolongation was enhanced by anti-Thy1.2 and anti-NK1.1 mAbs in TCR{delta}-/- mice. Therefore, in addition to CD4 and CD8 T cells, {gamma}{delta} T cells and NK cells play a role in resisting engraftment of rat marrow and the induction of xenograft tolerance in mice.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. Miyagawa, T. Kubo, K. Matsunami, T. Kusama, K. Beppu, H. Nozaki, T. Moritan, C. Ahn, J. Y. Kim, D. Fukuta, et al.
Delta-Short Consensus Repeat 4-Decay Accelerating Factor (DAF: CD55) Inhibits Complement-Mediated Cytolysis but Not NK Cell-Mediated Cytolysis
J. Immunol., September 15, 2004; 173(6): 3945 - 3952.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. J. Lavender, B. J. Ma, E. T. Silver, and K. P. Kane
The Rat RT1-A1c MHC Molecule Is a Xenogeneic Ligand Recognized by the Mouse Activating Ly-49W and Inhibitory Ly-49G Receptors
J. Immunol., March 15, 2004; 172(6): 3518 - 3526.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Zoller
Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host
J. Immunol., December 15, 2003; 171(12): 6941 - 6953.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Arber, A. BitMansour, T. E. Sparer, J. P. Higgins, E. S. Mocarski, I. L. Weissman, J. A. Shizuru, and J. M. Y. Brown
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation
Blood, July 15, 2003; 102(2): 421 - 428.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhao, H. Ohdan, J. O. Manilay, and M. Sykes
NK Cell Tolerance in Mixed Allogeneic Chimeras
J. Immunol., June 1, 2003; 170(11): 5398 - 5405.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Hummel, D. Wilms, M. Vitacolonna, and M. Zoller
Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host
J. Leukoc. Biol., November 1, 2002; 72(5): 898 - 912.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Sharland, A. Patel, J. H. Lee, A. E. Cestra, S. Saidman, and G. L. Waneck
Genetically Modified HLA Class I Molecules Able to Inhibit Human NK Cells Without Provoking Alloreactive CD8+ CTLs
J. Immunol., April 1, 2002; 168(7): 3266 - 3274.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Abe, J. Cheng, J. Qi, R. M. Glaser, A. D. Thall, M. Sykes, and Y.-G. Yang
Elimination of Porcine Hemopoietic Cells by Macrophages in Mice
J. Immunol., January 15, 2002; 168(2): 621 - 628.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.